Correction
Correction
Due to an American Health Consultants error, the dosage information in the Pharmacology Update on Rosiglitazone (Intern Med Alert 1999;21:110) is incorrect. The sentences should have read: "The recommended starting dose for rosiglitazone is 4 mg daily adminstered qd or bid. . . . The difference in glycosylated hemoglobin was significantly greater with 8 mg qd vs. 4 mg bid but not statistically different at 4 mg qd vs. 2 mg bid." We regret any confusion this may have caused.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.